Intravitreal Ziv-Aflibercept in Treatment of Naïve Chronic Central Serous Chorioretinopathy Related Choroidal Neovascular Membrane

Abstract EN

Purpose.

To study the effect and outcome of intravitreal Ziv-Aflibercept (IVZ) in treatment of Chronic Central Serous Chorioretinopathy (CSCR) related Choroidal Neovascular Membrane (CNVM).

Methods.

A case report of 48-year-old male patient treated with 1.25 mg/0.05 ml IVZ (total 3 doses at monthly intervals) in CSCR related CNVM.

Pre- and posttreatment fundus fluorescein angiography (FFA) and Optical Coherence Tomography (OCT) were done to document response along with improvement in visual acuity.

Patients.

Single eye of a 48-year-old male patient.

Results.

Regression of CNVM was noted with improvement of macular contour and thickness on OCT and cessation of leakage on FFA.

Visual acuity improved from 3/60,

Discussion.

Anti-VEGF injections have shown benefit in treatment of CNVM.

There is very little information about benefit of IVZ in CSCR related CNVM.

Conclusion.

IVZ is effective in regression of CSCR related CNVM and is associated with better macular anatomy and improved visual function.